“eli-lilly” Archives

in
Entry Author Date Location
FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats 10/09/20 Europe
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China 09/30/20 New York
Athira CEO Kawas: Alzheimer’s Drug Aims for “Recovery of Brain Function” 09/23/20 Seattle
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures 09/05/20 Boston
Roche Pays $120M for Rights to UCB’s Tau-Targeting Alzheimer’s Drug 07/29/20 Europe
Elevation Oncology Debuts With $32.5M to Develop Targeted Cancer Drugs 07/21/20 New York
GSK Pays CureVac $328M in mRNA Vaccines Pact—Excluding COVID-19 07/20/20 Europe
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact 07/14/20 Boston
Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech 06/02/20 Seattle
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs 05/29/20 Boston
FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies 05/28/20 National
AbCellera Raises $105M to Advance Antibody Discovery Operations 05/27/20 Seattle
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
Eli Lilly Gets Edge in the “RET” Race With FDA Nod for Cancer Drug 05/08/20 Indiana
AstraZeneca Diabetes Drug Gets FDA OK for Reducing Heart Health Risks 05/06/20 National
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
Neurology at Forefront of FDA’s Complex Innovative Trial Design Pilot 04/16/20 National
With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer 04/15/20 Boston
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Biohaven’s Acute Migraine Drug Bests Placebo in Prevention Study 03/30/20 National
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes 03/23/20 Europe
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening 03/17/20 National
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Biohaven’s Migraine Pill Is the Latest CGRP Drug to Win the FDA’s OK 02/27/20 New York
Invetx Fetches $15M to Develop Biologic Drugs for Man’s Best Friend 02/24/20 Boston
Lundbeck’s Alder Bio Bet Pays Off With FDA Approval of Migraine Drug 02/23/20 National
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Page 1 of 20 next page »